Maria‐Luisa Schubert

Statistics

Publications

Citations

1.5K

H-Index

Active since

2016

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

National Center for Tumor Diseases

Deutsches Konsortium für Translationale Krebsforschung

German Cancer Research Center

Maria‐Luisa Schubert is an author at Heidelberg University specializing in immunotherapy, chimeric antigen receptor t-cell therapy, and cancer immunotherapy.

ORCID

Publications per year

2016–2024

Publications

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir et al. · Nature Medicine · 2023 · 226 citations · Full text

Life Sciences, Immunology, Oncology +16

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients

Jean‐Marc Hoffmann, Maria‐Luisa Schubert, Lei Wang et al. · Frontiers in Immunology · 2018 · 99 citations · Full text

Life Sciences, Hematology, Immunology +17

Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients

Sophia Stock, Rudolf Übelhart, Maria‐Luisa Schubert et al. · International Journal of Cancer · 2019 · 80 citations · Full text

Life Sciences, Hematology, Immunology +17

Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL

Felix Korell, Sascha Laier, Sandra Sauer et al. · Cells · 2020 · 74 citations · Full text

Life Sciences, Immunology, Oncology +17

Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients

Fuli Fan, Sophia Stock, Lei Wang et al. · International Journal of Cancer · 2020 · 73 citations · Full text

Medicine, Hematology, Pharmacology +17

1–5 of 33